- Home
- AMPY vs SLGL Comparison
AMPY vs SLGL Comparison
Compare AMPY & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMPY | SLGL |
|---|---|---|
| Founded | 2011 | 1997 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.6M | 159.7M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AMPY | SLGL |
|---|---|---|
| Price | $5.17 | $73.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $110.00 |
| AVG Volume (30 Days) | ★ 570.0K | 27.6K |
| Earning Date | 03-04-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $275,827,100.00 | $18,970,000.00 |
| Revenue This Year | N/A | $122.71 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 62.04 |
| 52 Week Low | $2.27 | $4.02 |
| 52 Week High | $6.55 | $76.80 |
Technical Indicators
Market Signals| Indicator | AMPY | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 59.91 |
| Support Level | $5.18 | $62.08 |
| Resistance Level | $5.75 | $76.80 |
| Average True Range (ATR) | 0.26 | 6.94 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 47.12 | 63.92 |
Price Performance
Historical ComparisonAbout AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.